Progress Update on MedMira’s COVID-19 Product Family
Halifax, Nova Scotia, 29 January, 2021 – Today, MedMira Inc. (MedMira) (TSXV: MIR) announces the development of a rapid antibody test...
Progress Update on MedMira’s COVID-19 Product Family
MedMira Announces Product Update
MedMira reports additional independent performance evaluation results of REVEALCOVID-19™
MedMira Announces Update on Development of Point-of-Care Antibody Test